PRP vs. PRF: What's the Difference?

PRP vs. PRF: What's the Difference?

Quick answer: PRP (platelet-rich plasma) and PRF (platelet-rich fibrin) are both concentrates made from your own blood. PRP is usually spun with an anticoagulant; L-PRF, the form of PRF described in a 2025 Periodontology 2000 review, is spun without one, so a fibrin network forms, though there is no consensus on how PRF should be prepared. A 2025 aesthetic-medicine review found few direct comparisons, and the evidence for both is small and mixed. Office PRP injection is off-label.

Medically reviewed by Dr. Hootan Zandifar, MD, Medical Director, Regen Therapy MD (UCLA David Geffen School of Medicine). Educational information only — not medical advice; individual results vary.

What are PRP and PRF?

PRP and PRF are autologous platelet concentrates, meaning preparations made from a patient's own blood in which platelets are gathered into a small volume. Platelets carry proteins called growth factors, and clinicians have studied these concentrates in dentistry, orthopedics, dermatology and hair care.

A 2025 narrative review in Periodontology 2000 from a dental research group calls PRP the "first generation" of these products and PRF the "second generation." The label is not a ranking of which is better for any person.

How are PRP and PRF prepared differently?

Preparation is the core difference. This section describes the general approach only; it is not a protocol, and the exact steps vary by device and clinic.

Anticoagulant versus no anticoagulant

According to the Periodontology 2000 review, PRP protocols vary but generally involve two spins in a centrifuge, with an anticoagulant added first and an activator added afterward. The anticoagulant keeps the blood from clotting in the tube. The authors note that these added chemicals may interfere with the body's natural tissue-repair processes and the release of bioactive molecules. The review calls for standardized reporting of protocol details so that these differences can be compared.

The form of PRF described in the review (L-PRF) uses a single spin and no anticoagulant or activator; a separate 2024 review notes there is no consensus on how PRF should be prepared. Because blood begins clotting almost immediately, the review notes that the tube has to be handled promptly. The authors describe PRF as simpler and less expensive to prepare than PRP.

The fibrin network

Without an anticoagulant, the blood clots and a three-dimensional fibrin network forms. The Periodontology 2000 review describes the two products as differing in their cell content, their protein release and the formation of that fibrin network.

White blood cells (leukocytes)

Leukocyte content is one of the two features used to sort platelet concentrates into families. A 2012 laboratory comparison in Current Pharmaceutical Biotechnology named leukocyte content and fibrin architecture as the two classifying features, yielding four families. The Periodontology 2000 review states that the role of leukocytes and centrifugation settings is still unclear.

What does the laboratory data show?

In that 2012 study, researchers compared one pure PRP gel preparation (the PRGF technique) with leukocyte- and platelet-rich fibrin membranes made by one PRF method (L-PRF) in culture medium. This was laboratory work with prepared material, not a study in patients. Over seven days, the fibrin membranes released significantly larger amounts of several growth factors (TGF-beta1, PDGF-AB and VEGF) and matrix proteins, and they released them slowly over that period. The PRP gels dissolved in under five days, while the fibrin membranes were still intact at seven days.

These findings show that these two specific preparations behaved differently in a dish. They do not show that one produces better outcomes in a person, and this study did not measure outcomes in patients.

What does clinical evidence say about PRP versus PRF?

The reviews cited here describe human research that is small, varied in method, and inconsistent in how protocols are reported. The 2025 Periodontology 2000 review says that inconsistent reporting has led to conflicting conclusions and that standardized classification is needed.

Aesthetics and skin

A 2025 narrative review by Davies and Miron in Periodontology 2000 searched for randomized trials of platelet concentrates in aesthetic medicine and included 96 articles. Most studies used PRP. The authors report that only a few studies compared PRP with PRF directly, and those favored PRF. They also noted small sample sizes and a lack of standardized assessment criteria, and called for well-designed randomized trials. One disclosure is worth knowing: the second author, Richard Miron, declares that he is the founder of BioPRF, a PRF company, which is a potential conflict of interest.

A 2025 systematic review in Annals of Plastic Surgery pooled PRP and PRF studies in facial rejuvenation: 20 articles covering 514 patients, including controlled trials, cohorts and case series. The share of studies reporting a significant improvement ranged from 80% for skin thickness and 75% for elasticity down to 40% for wrinkles, 33% for texture, 17% for pigmentation changes and 0% for hydration. Skin thickness, elasticity and hydration were each assessed in only four to six studies, so these percentages rest on small numbers. No serious adverse events were reported. The authors described effectiveness as controversial, with mixed results.

Hair loss

For androgenetic alopecia (pattern hair loss), the sources reviewed here include a meta-analysis of randomized trials for PRP and a narrative review for PRF. A 2023 meta-analysis of nine randomized trials with 238 patients, published in the Journal of Cutaneous Medicine and Surgery, found that hair density was higher with PRP than with placebo at 3 and 6 months. Hair count and hair diameter increased from baseline but did not differ significantly from placebo. Some included studies reported adverse reactions, and none were described as serious. The pooled sample was small, and the abstract reports hair density comparisons at 3 and 6 months.

A 2024 narrative review in the Journal of Cosmetic Dermatology looked at PRF for hair loss. It reported that five clinical studies found a significant effect, that there is no consensus on how PRF should be prepared, and that larger, well-designed studies are needed to confirm any advantage of PRF over PRP.

What the evidence does not tell us

  • It does not establish that PRF is better than PRP, or PRP better than PRF, for any specific condition.
  • It does not tell an individual patient what to expect; the figures above are group results.
  • It does not settle which preparation details matter, because those details are reported inconsistently.

How are PRP and PRF regulated by the FDA?

As of a 2015 review in the Journal of Knee Surgery, PRP blood products fell under FDA oversight through the Center for Biologics Evaluation and Research, and PRP preparation systems reached the market through the 510(k) pathway. Nearly all were cleared for producing preparations that are mixed with bone graft material. Office PRP injection was therefore off-label at that time, and clinics should be asked about the current status. Clinicians may use a product off-label when they are well informed and base that use on sound evidence.

That paper addresses PRP, not PRF. If a clinic offers either product, ask how it is regulated for the specific use being proposed and what evidence supports that use.

How should you think about PRP versus PRF as a patient?

Because the research on both products is limited and mixed, compare the specific evidence for the specific concern you have. For hair, our overview of PRP for hair loss covers one use in more depth, and for joints, see what the evidence says about PRP for knee arthritis.

Questions worth asking any clinic

  1. Which product do you use for my concern, and what published human studies support that use?
  2. How is it prepared, and is the device cleared for this purpose or is use off-label?
  3. What are the known risks and the realistic limits of the evidence?
  4. Who prepares and administers it, and who supervises?
  5. What is the full cost, and what happens if I do not notice a difference?

At Regen Therapy MD, a physician reviews your history before any program. You can read about our PRP and PRF services in Beverly Hills and see the clinic's pricing information before deciding whether to book a consult.

Frequently asked questions

Is PRF better than PRP?

Current research does not show that one is better for patients across conditions. A seven-day laboratory study (not in patients) found L-PRF fibrin membranes released larger amounts of several growth factors than one type of PRP gel, and a few aesthetic comparisons, in a review whose second author founded a PRF company, favored PRF, but those studies had small samples and no standardized assessment. Office PRP injection is off-label; ask the clinic how PRF is regulated for the proposed use. Individual results vary.

What is the main difference between PRP and PRF?

PRP is generally prepared with an anticoagulant and two spins. PRF, as described in the L-PRF literature, is generally prepared in one spin without an anticoagulant, so a fibrin network forms, though a 2024 review notes there is no consensus on PRF preparation. Reviews note the evidence on whether this changes outcomes is limited and inconsistent, and neither is promised to produce any specific result.

Does PRF use blood from another person?

As described in the sources cited here, both PRP and PRF are autologous, meaning they are made from your own blood. Being autologous does not remove all risk. Office PRP injection is off-label; ask the clinic how PRF is regulated for the proposed use.

Is PRP or PRF used for hair loss?

Both have been studied for pattern hair loss. A 2023 meta-analysis of nine randomized trials found higher hair density with PRP than placebo at 3 and 6 months, but hair count and diameter did not differ significantly. A 2024 review identified five clinical studies of PRF for pattern hair loss and calls for larger, well-designed studies to confirm any benefit over PRP, so benefit is uncertain. Office PRP injection is off-label; ask how PRF is regulated.

Are there side effects?

The two systematic reviews that reported on safety (facial rejuvenation and hair loss) described no serious adverse events, but some included studies reported adverse reactions and the studies were small, so rare risks may not have been captured. Ask a physician to review your health history and medications and to explain the risks of any needle-based procedure before you decide.

Talk with a Regen Therapy MD physician

If you'd like to talk through whether any of these options fit your health history, start with a physician consult, not a product.

  • Book a consult: https://book.mypatientnow.com/practice/TqZLiT
  • Call: (424) 349-6008
  • Cost: $295 consult, credited 100% toward your first program
  • Clinics: Beverly Hills (8920 Wilshire Blvd) and Santa Monica (2811 Wilshire Blvd). Telehealth and peptide shipping are available only where we are licensed.

Sources

  1. Calciolari E, et al. Differences between first- and second-generation autologous platelet concentrates. Periodontol 2000. 2025. PMID 38487938. https://pubmed.ncbi.nlm.nih.gov/38487938/
  2. Dohan Ehrenfest DM, et al. Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF). Curr Pharm Biotechnol. 2012. PMID 21740377. https://pubmed.ncbi.nlm.nih.gov/21740377/
  3. Davies C, et al. Autolougous platelet concentrates in esthetic medicine. Periodontol 2000. 2025. PMID 39086171. https://pubmed.ncbi.nlm.nih.gov/39086171/
  4. Qin N, et al. Systematic Review of Platelet-Rich Plasma and Platelet-Rich Fibrin in Facial Rejuvenation. Ann Plast Surg. 2025. PMID 40167104. https://pubmed.ncbi.nlm.nih.gov/40167104/
  5. Zhang X, et al. Platelet-Rich Plasma for Androgenetic Alopecia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Cutan Med Surg. 2023. PMID 37533146. https://pubmed.ncbi.nlm.nih.gov/37533146/
  6. Shrestha S, et al. Platelet-rich fibrin: A review of its role as a new treatment in androgenetic alopecia. J Cosmet Dermatol. 2024. PMID 38641925. https://pubmed.ncbi.nlm.nih.gov/38641925/
  7. Beitzel K, et al. US definitions, current use, and FDA stance on use of platelet-rich plasma in sports medicine. J Knee Surg. 2015. PMID 25268794. https://pubmed.ncbi.nlm.nih.gov/25268794/

Educational disclaimer

This article is for educational purposes only and is not medical advice, diagnosis, or treatment. It doesn't establish a doctor-patient relationship or confirm that you are a candidate for any therapy. Individual results vary, and no outcome is promised. Study figures are group results from the cited publications, not predictions for any individual. Compounded drugs are not FDA-approved, and FDA-approved brand products and compounded preparations are not interchangeable. Retatrutide is investigational. This article doesn't provide dosing or treatment protocols. Talk with a licensed clinician about your own situation. If you have a medical emergency, call 911.

Blogs & News

Discover valuable resources

More Blogs
Benchtop centrifuge holding tubes of separated golden plasma beside an empty treatment chair in a clinic room
November 8, 2026
PRP vs. PRF: What's the Difference?
Learn more
November 7, 2026
Did HHS Approve Peptides? What the New Policy Really Means
Learn more
October 16, 2026
Best Peptides for Weight Loss: A Physician's Guide
Learn more
Free download

The Patient's Guide to Peptides — what peptides actually are (plain English), why sourcing matters, and the 3 questions that reveal a real medical program. Peer-reviewed sources included. Get the free PDF →

Ready when you are

Talk to a physician about your goals.

A real evaluation, your own lab data, and a plan built around your goals — needle-free with the Peptide Patch where it fits (select non-GLP-1 peptides only; GLP-1 medications such as semaglutide and tirzepatide are injection-only), plus conventional peptides when they're the better route.

Book a consultation →

Beverly Hills · Santa Monica · Telehealth where licensed